Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries?

Vaccine

Volumn 29, Issue 6, 2011, Pages 1242-1247

  Chan, J ^a,c   Nirwati, H ^d   Triasih, R ^d,e   Bogdanovic Sakran, N ^b   Soenarto, Y ^d,e   Hakimi, M ^d,e   Duke, T ^a,c   Buttery, J P ^a,b,f   Bines, J E ^b,c   Bishop, R F ^b,c   Kirkwood, C D ^b,c   Danchin, M D ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d GADJAH MADA UNIVERSITY   (Indonesia)

^e Dr Sardjito Hospital   (Indonesia)

^f MONASH UNIVERSITY   (Australia)

Author keywords

Developing countries; Maternal antibodies; Rotavirus gastroenteritis; Vaccines

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LIVE VACCINE; MATERNAL ANTIBODY; ROTAVIRUS VACCINE; VIRUS ANTIBODY;

ADULT; ARTICLE; BREAST MILK; COLOSTRUM; DEVELOPING COUNTRY; FEMALE; HUMAN; INFANT; MOTHER CHILD RELATION; PRIORITY JOURNAL; ROTAVIRUS INFECTION; UMBILICAL CORD BLOOD;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; COLOSTRUM; DEVELOPING COUNTRIES; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INDONESIA; MILK, HUMAN; PREGNANCY; PROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; YOUNG ADULT;

EID: 78751579038     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.087     Document Type: Article

References (41)

1. Parashar U.D., Burton A., Lanata C., et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009, 200(November (Suppl. 1)):S9-S15.
2. WHO Strategic Advisory Group of Experts (SAGE) on Immunisation. Weekly epidemiological record. 2009; 84th year June (23):213-236.
3. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(January (1)):11-22.
4. Vesikari T., Matson D.O., Dennehy P., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(January (1)):23-33.
5. Orozco M., Vasquez J., Pedreira C., et al. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. J Infect Dis 2009, 200(November (Suppl. 1)):S125-130.
6. Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr Infect Dis J; 29 April (4):319-323.
7. Lambert S.B., Faux C.E., Hall L., et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust 2009, 191(August (3)):157-160.
8. Clark H.F., Lawley D., Mallette L.A., DiNubile M.J., Hodinka R.L. Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin Vaccine Immunol 2009, 16(March (3)):382-386.
9. Bresee J.S., Glass R.I., Ivanoff B., Gentsch J.R. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999, 17(May (18)):2207-2222.
10. John TJ. Antibody response of infants in tropics to five doses of oral polio vaccine. Br Med J. 1976;1 April (6013):812.
11. Linhares A.C., Gabbay Y.B., Mascarenhas J.D., et al. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull World Health Organ 1996, 74(5):491-500.
12. Patriarca P.A., Wright P.F., John T.J. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991, 13(Septenber-October (5)):926-939.
13. Suharyono, Simanjuntak C., Witham N., et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet 1992, 340(September (8821)):689-694.
14. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet; 376 (August (9741)):606-614.
15. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet; 376 (August (9741)):615-623.
16. Vesikari T., Karvonen A., Puustinen L., et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr Infect Dis J 2004, 23(October (10)):937-943.
17. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med; 362, January (4):289-298.
18. Patel M., Pedreira C., De Oliveira L.H., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009, 301(Jun (1)):2243-2251.
19. Glass R.I., Bresee J.S., Turcios R., Fischer T.K., Parashar U.D., Steele A.D. Rotavirus vaccines: targeting the developing world. J Infect Dis. 2005, 192(Sep (Suppl. 1)):S160-166.
20. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med.; 362 (January (4)):299-305.
21. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis. 2009; 200 (November (Suppl. 1)):S39-48.
22. Rennels M.B. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 1996, 174(September (Suppl. 1)):S107-111.
23. Ray P.G., Kelkar S.D. Prevalence of neutralizing antibodies against different rotavirus serotypes in children with severe rotavirus-induced diarrhea and their mothers. Clin Diagn Lab Immunol 2004, 11(January (1)):186-194.
24. Asensi M.T., Martinez-Costa C., Buesa J. Anti-rotavirus antibodies in human milk: quantification and neutralizing activity. J Pediatr Gastroenterol Nutr 2006, 42(May (5)):560-567.
25. Brussow H., Benitez O., Uribe F., Sidoti J., Rosa K., Cravioto A. Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life. J Clin Microbiol 1993, 31(March (3)):593-597.
26. Losonsky G.A., D'Alessandra de Rimer H. Rotavirus specific breast milk antibody in two populations and possible correlates of protection. Adv Exp Med Biol 1991, 310:265-269.
27. Moon SS, Wang Y, Shane AL, et al. Inhibitory effect of breast milk on infectivity of live Oral rotavirus vaccines. Pediatr Infect Dis J. May 3, 2010.
28. Soenarto Y., Aman A.T., Bakri A., et al. Burden of severe rotavirus diarrhea in indonesia. J Infect Dis 2009, 200(November (Suppl. 1)):S188-194.
29. Bishop R.F., Bugg H.C., Masendycz P.J., Lund J.S., Gorrell R.J., Barnes G.L. Serum, fecal, and breast milk rotavirus antibodies as indices of infection in mother-infant pairs. J Infect Dis 1996, 174(September (Suppl. 1)):S22-29.
30. Bishop R.F., Cipriani E., Lund J.S., Barnes G.L., Hosking C.S. Estimation of rotavirus immunoglobulin G antibodies in human serum samples by enzyme-linked immunosorbent assay: expression of results as units derived from a standard curve. J Clin Microbiol 1984, 19(April (4)):447-452.
31. McLean B., Holmes I.H. Transfer of antirotaviral antibodies from mothers to their infants. J Clin Microbiol 1980, 12(Septenber (3)):320-325.
32. Brussow H., Sidoti J., Lerner L., et al. Antibodies to seven rotavirus serotypes in cord sera, maternal sera, and colostrum of German women. J Clin Microbiol 1991, 29(December (12)):2856-2859.
33. Ward R.L., Knowlton D.R., Zito E.T., Davidson B.L., Rappaport R., Mack M.E. Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group. J Infect Dis 1997, 176(Septenber (3)):570-577.
34. Rennels M.B., Wasserman S.S., Glass R.I., Keane V.A. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group. Pediatrics 1995, 96(December (6)):1132-1136.
35. Inglis G.C., Sommerville R.G., McLelland D.B. Anti-rotavirus antibody in human colostrum. Lancet 1978, 1(March (8063)):559-560.
36. Nagura H., Nakane P.K., Brown W.R. Breast milk IgA binds to jejunal epithelium in suckling rats. J Immunol 1978, 120(April (4)):1333-1339.
37. Rahman M.M., Yamauchi M., Hanada N., Nishikawa K., Morishima T. Local production of rotavirus specific IgA in breast tissue and transfer to neonates. Arch Dis Child 1987, 62(April (4)):401-405.
38. Newburg D.S., Peterson J.A., Ruiz-Palacios G.M., et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998, 351(April (9110)):1160-1164.
39. Van Man N., Luan le T., Trach D.D., et al. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis 2005, 192(September (Suppl. 1)):S127-132.
40. Danchin M.H., Bines J.E. Defeating rotavirus? The global recommendation for rotavirus vaccination. N Engl J Med 2009, 361(November (20)):1919-1921.
41. Edmond K.M., Zandoh C., Quigley M.A., Amenga-Etego S., Owusu-Agyei S., Kirkwood B.R. Delayed breastfeeding initiation increases risk of neonatal mortality. Pediatrics Mar 2006, 117(3):e380-386.